CCOc1ccc(N/C(Cl)=C(Cl)\C(=C(\Nc2ccc(OCC)cc2)n2nnc3ccccc32)[N+](=O)[O-])cc1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?